RPS6KB1 and Huntington disease: Consistent with this concept, deletion of Igf1r, an upstream activator of S6K1 signalling, had some benefits in N171-82Q HD mice, but this manipulation was not associated with a reduction in the phosphorylation p70S6k, suggesting that suppression of S6K1 activity was not mediating these effects28.